Cargando…

FGF21 regulates hepatic metabolic pathways to improve steatosis and inflammation

The prevalence of non-alcoholic fatty liver disease (NAFLD) has increased dramatically worldwide and, subsequently, also the risk of developing non-alcoholic steatohepatitis (NASH), hepatic fibrosis, cirrhosis and cancer. Today, weight loss is the only available treatment, but administration of fibr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Keinicke, Helle, Sun, Gao, Mentzel, Caroline M Junker, Fredholm, Merete, John, Linu Mary, Andersen, Birgitte, Raun, Kirsten, Kjaergaard, Marina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424338/ https://www.ncbi.nlm.nih.gov/pubmed/32688339 http://dx.doi.org/10.1530/EC-20-0152

Ejemplares similares

Joint Profiling of miRNAs and mRNAs Reveals miRNA Mediated Gene Regulation in the Göttingen Minipig Obesity Model
por: Mentzel, Caroline M. Junker, et al.
Publicado: (2016)

FGF19 and FGF21 for the Treatment of NASH—Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human
por: Henriksson, Emma, et al.
Publicado: (2020)

CREBH-FGF21 axis improves hepatic steatosis by suppressing adipose tissue lipolysis
por: Park, Jong-Gil, et al.
Publicado: (2016)

miR-22 inhibition reduces hepatic steatosis via FGF21 and FGFR1 induction
por: Hu, Ying, et al.
Publicado: (2020)

Breeding schemes for intervertebral disc disease in dachshunds: Is disc calcification score preferable to genotyping of the FGF4 retrogene insertion on CFA12?
por: Bruun, Camilla Sichlau, et al.
Publicado: (2020)

Metformin Stimulates FGF21 Expression in Primary Hepatocytes
por: Nygaard, Eva B., et al.
Publicado: (2012)

Hypothalamic oxidative stress and inflammation, and peripheral glucose homeostasis in Sprague-Dawley rat offspring exposed to maternal and postnatal chocolate and soft drink
por: Kjaergaard, Marina, et al.
Publicado: (2018)

Bitter melon extract attenuating hepatic steatosis may be mediated by FGF21 and AMPK/Sirt1 signaling in mice
por: Yu, Yongmei, et al.
Publicado: (2013)

Nutritional Regulation of Hepatic FGF21 by Dietary Restriction of Methionine
por: Fang, Han, et al.
Publicado: (2021)

Altered Methylation Profile of Lymphocytes Is Concordant with Perturbation of Lipids Metabolism and Inflammatory Response in Obesity
por: Jacobsen, Mette J., et al.
Publicado: (2016)

Hepatic FGF21 preserves thermoregulation and cardiovascular function during bacterial inflammation
por: Huen, Sarah C., et al.
Publicado: (2021)

Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity
por: Agrawal, Archita, et al.
Publicado: (2018)

Preclinical Weight Loss Efficacy of AM833 in Combination With Semaglutide in Rodent Models of Obesity
por: John, Linu M, et al.
Publicado: (2021)

Gender and Obesity Specific MicroRNA Expression in Adipose Tissue from Lean and Obese Pigs
por: Mentzel, Caroline M. Junker, et al.
Publicado: (2015)

Subcutaneous delivery of FGF21 mRNA therapy reverses obesity, insulin resistance, and hepatic steatosis in diet-induced obese mice
por: Bartesaghi, Stefano, et al.
Publicado: (2022)

A pyrexic effect of FGF21 independent of energy expenditure and UCP1
por: Zouhar, Petr, et al.
Publicado: (2021)

FGF19 subfamily members: FGF19 and FGF21
por: Dolegowska, Katarzyna, et al.
Publicado: (2019)

Combined genetic deletion of GDF15 and FGF21 has modest effects on body weight, hepatic steatosis and insulin resistance in high fat fed mice
por: Patel, Satish, et al.
Publicado: (2022)

Activation of Liver FGF21 in hepatocarcinogenesis and during hepatic stress
por: Yang, Chaofeng, et al.
Publicado: (2013)

Hepatic hormone FGF21 and its analogues in clinical trials
por: Shao, Weijuan, et al.
Publicado: (2022)

FGF2 disruption enhances thermogenesis in brown and beige fat to protect against adiposity and hepatic steatosis
por: Li, Haifang, et al.
Publicado: (2021)

Fibroblast Growth Factor 21 (FGF21) Administration Sex-Specifically Affects Blood Insulin Levels and Liver Steatosis in Obese A(y) Mice
por: Makarova, Elena, et al.
Publicado: (2021)

Potential developmental neurotoxicity of pesticides used in Europe
por: Bjørling-Poulsen, Marina, et al.
Publicado: (2008)

FGF19 and FGF21: In NASH we trust
por: Talukdar, Saswata, et al.
Publicado: (2020)

Hepatic Fgf21 Expression Is Repressed after Simvastatin Treatment in Mice
por: Ziros, Panos, et al.
Publicado: (2016)

Suppressive Effect of Autocrine FGF21 on Autophagy-Deficient Hepatic Tumorigenesis
por: Kim, Jinyoung, et al.
Publicado: (2022)

Beyond appetite regulation: Targeting energy expenditure, fat oxidation, and lean mass preservation for sustainable weight loss
por: Christoffersen, Berit Østergaard, et al.
Publicado: (2022)

TRIF Differentially Regulates Hepatic Steatosis and Inflammation/Fibrosis in Mice
por: Yang, Ling, et al.
Publicado: (2017)

Hepatic steatosis in patients with acromegaly
por: Koutsou‐Tassopoulou, Andreani, et al.
Publicado: (2019)

FGF21 and Cardiac Physiopathology
por: Planavila, Anna, et al.
Publicado: (2015)

Fundamentals of FGF19 & FGF21 Action In Vitro and In Vivo
por: Adams, Andrew C., et al.
Publicado: (2012)

Aging is associated with increased FGF21 levels but unaltered FGF21 responsiveness in adipose tissue
por: Villarroya, Joan, et al.
Publicado: (2018)

Fibroblast Growth Factor 21 (FGF21) in Human Cerebrospinal Fluid: Relationship With Plasma FGF21 and Body Adiposity
por: Tan, Bee K., et al.
Publicado: (2011)

Anterograde regulation of mitochondrial genes and FGF21 signaling by hepatic LSD1
por: Cao, Yang, et al.
Publicado: (2021)

Prolonged breastfeeding protects from obesity by hypothalamic action of hepatic FGF21
por: Pena-Leon, Veronica, et al.
Publicado: (2022)

Hepatic FGF21: Its Emerging Role in Inter-Organ Crosstalk and Cancers
por: SUI, Yue, et al.
Publicado: (2022)

FGF21 as a Stress Hormone: The Roles of FGF21 in Stress Adaptation and the Treatment of Metabolic Diseases
por: Kim, Kook Hwan, et al.
Publicado: (2014)

ER Stress-induced Inflammasome Activation Contributes to Hepatic Inflammation and Steatosis
por: Zhang, Jinyu, et al.
Publicado: (2016)

CCN1 promotes hepatic steatosis and inflammation in non-alcoholic steatohepatitis
por: Ju, Linling, et al.
Publicado: (2020)

Epigallocatechin-3-gallate ameliorates hepatic damages by relieve FGF21 resistance and promotion of FGF21–AMPK pathway in mice fed a high fat diet
por: Zhang, Yuanyuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9lk2trkbfejchghbnmg6l50in8